Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) model
Sara Marie Atkinson, Janine Bleil, Rene Maier, Anja A. Kuehl, Mette Thorn, Kyle Serikawa, Brian Fox, Kim Kruse, Claus Haase, Soren Skov, Anneline Nansen, Uta Syrbe
Dive into the research topics of 'Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) model'. Together they form a unique fingerprint.